NewLink Genetics Corporation – Trademark Portfolio

Entity Type: 03

NewLink Genetics Corporation holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. The owner is based in Ames, IA.

2503 South Loop Drive, Suite 5100

Ames, IA 50010

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

NewLink Genetics Corporation's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

16
Paper Goods (3 filings)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does NewLink Genetics Corporation have?

NewLink Genetics Corporation has 10 U.S. trademarks filed with the USPTO.

What trademark classes does NewLink Genetics Corporation file in?

NewLink Genetics Corporation files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 16 (Paper Goods), Class 9 (Computers & Electronics). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is NewLink Genetics Corporation's trademark registration success rate?

NewLink Genetics Corporation has a 0% trademark registration rate, with 0 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.